Centers for Disease Control and Prevention. Tetanus among injecting-drug users-California, 1997. Morbidity and Mortality Weekly Report
1998; 47(8): 149–151.
Bennett, J, et al.
Bundling, a newly identified risk factor for neonatal tetanus: implications for global control. International Journal of Epidemiology
1996; 25: 879–884.
Filia, A, et al.
Tetanus in Italy 2001–2010: a continuing threat in older adults. Vaccine
2014; 32: 639–644.
Yildirim, RC, et al.
Tetanus IgG antibody levels in children aged 12 to 47 months in Turkey. American Journal of Infection Control
2001; 29: 120–124.
Edsall, G, et al.
Excessive use of tetanus toxoid boosters. The Journal of the American Medical Association
1967; 202: 111–113.
National Advisory Committee on Immunization (NACI). Interval between administration of vaccines against diphtheria, tetanus, and pertussis. Canada Communicable Disease Report
2005; 31(ACS-9): 17–22.
Chatchatee, P, et al.
Seroprevalence of tetanus antibody in the Thai population: a national survey. Asian Pacific Journal of Allergy and Immunology
2007; 25: 219–223.
Centers for Disease Control and Prevention. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP) Morbidity and Mortality Weekly Report
2006; 55(RR-03): 1–34.
World Health Organization. Tetanus vaccine: WHO position paper. The Weekly Epidemiological Record
2006; 81: 198–208.
Coulibaly, N, De Serres, G. Couverture vaccinale antitétanique des adultes au Canada-année 2002. Canadian Journal of Public Health
2004; 95: 456–459.
Maple, PAC, et al.
Immunity to diphtheria and tetanus in England and Wales. Vaccine
2001; 19: 167–173.
Schatz, D, et al.
Aging and the immune response to tetanus toxoid: diminished frequency and level of cellular immune reactivity to antigenic stimulation. Clinical and Diagnostic Laboratory Immunology
1998; 5: 894–896.
Peel, MM, et al.
Relationship between lymphocyte response to tetanus toxoid and age of lymphocyte donor. The Journal of Hygiene
1978; 80: 259–265.
Bayas, JM, et al.
Immunogenicity and reactogenicity of the adult tetanus-diphtheria vaccine. How many doses are necessary?
Epidemiology and Infection
2001; 127: 451–460.
Hüllstrung, HD, et al.
Tetanus immunisation in geriatric patients with accidental wounds: how much is needed?
Swiss Medical Weekly
2003; 133: 227–232.
Hammarlund, E, et al.
Durability of vaccine-induced immunity against tetanus and diphtheria toxins: a cross-sectional analysis. Clinical Infectious Diseases
2016; 62: 1111–1118.
Gottlieb, S, et al.
(1964) Long-term immunity to tetanus—a statistical evaluation and its clinical implications. American Journal of Public Health Nation Health
1964; 54: 961–971.
Chithra, A, et al.
Role of rapid tetanus antibody test in accident and emergency department. Journal of Maxillofacial and Oral Surgery
2015; 14: 784–788.